Purinergic control of red blood cell metabolism: Novel strategies to improve red cell storage quality

Blood Transfusion

Volumn 15, Issue 6, 2017, Pages 535-542

  Sun, Kaiqi ^a,b   D'Alessandro, Angelo ^c   Xia, Yang ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Additive solution; Adenosine; Metabolomics; Packed red blood cells; Transfusion medicine

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; OXYGEN; PROTEOME; ADENOSINE RECEPTOR; GLUCOSE;

ALTITUDE DISEASE; BLOOD BANK; BLOOD FLOW; DISEASE COURSE; ERYTHROCYTE METABOLISM; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; METABOLIC REGULATION; METABOLOME; NONHUMAN; PULMONARY HYPERTENSION; PURINERGIC SIGNALLING; QUALITY CONTROL; REVIEW; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; TISSUE INJURY; TRANSFUSION RELATED ACUTE LUNG INJURY; ANIMAL; BLOOD STORAGE; CYTOLOGY; ERYTHROCYTE; METABOLISM; METABOLOMICS; PROCEDURES;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; GLUCOSE; HUMANS; METABOLOME; METABOLOMICS; OXYGEN; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EID: 85031920966     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2017.0366-16     Document Type: Review

References (101)

1. Hess JR. An update on solutions for red cell storage. Vox Sang 2006; 91: 13-9.
2. Greenwalt TJ. A short history of transfusion medicine. Transfusion 1997; 37: 550-63.
3. Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev 2001; 15: 91-107.
4. Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: Red blood cell transfusion thresholds and storage. JAMA 2016; 316: 2025-35.
5. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39.
6. Steiner ME, Ness PE, Assmann SF, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 2015; 372: 1419-29.
7. Carson JL, Sieber F, Cook DR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015; 385: 1183-9.
8. Fergusson DA, Hébert P, Hogan DL, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: The ARIPI randomized trial. JAMA 2012; 308: 1443-51.
9. D habangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: The TOTAL randomized clinical trial. JAMA 2015; 314: 2514-23.
10. H eddle NM, Cook RJ, Arnold DM, et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. N Engl J Med 2016; 375: 1937-45.
11. L acroix J, Hébert PC, Fergusson DA, et al. Age of transfused blood in critically ill adults. N Engl J Med 2015; 372: 1410-8.
12. D' Alessandro A, Nemkov T, Yoshida T, et al. Citrate metabolism in red blood cells stored in additive solution-3. Transfusion 2017; 57: 325-33.
13. Re isz JA, Wither MJ, Dzieciatkowska M, et al. Oxidative modifications of glyceraldehyde 3-phosphate dehydrogenase regulate metabolic reprogramming of stored red blood cells. Blood 2016; 128: E32-42.
14. Wi ther M, Dzieciatkowska M, Nemkov T, et al. Hemoglobin oxidation at functional amino acid residues during routine storage of red blood cells. Transfusion 2016; 56: 421-6.
15. Ne mkov T, Hansen KC, Dumont LJ, D'Alessandro A. Metabolomics in transfusion medicine. Transfusion 2016; 56: 980-93.
16. Fu X, Felcyn JR, Odem-Davis K, Zimring JC. Bioactive lipids accumulate in stored red blood cells despite leukoreduction: A targeted metabolomics study. Transfusion 2016; 56: 2560-70.
17. D' Alessandro A, D'Amici GM, Vaglio S, Zolla L. Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: From metabolism to proteomics. Haematologica 2012; 97: 107-15.
18. de Wolski K, Fu X, Dumont LJ, et al. Metabolic pathways that correlate with post-transfusion circulation of stored murine red blood cells. Haematologica 2016; 101: 578-86.
19. Ka nias T, Sinchar D, Osei-Hwedieh D, et al. Testosteronedependent sex differences in red blood cell hemolysis in storage, stress, and disease. Transfusion 2016; 56: 2571-83.
20. Va n 't Erve TJ, Wagner BA, Martin SM, et al. The heritability of hemolysis in stored human red blood cells. Transfusion 2015; 55: 1178-85.
21. We isenhorn EM, van T Erve TJ, Riley NM, et al. Multi-omics evidence for inheritance of energy pathways in red blood cells. Mol Cell Proteomics 2016; 15: 3614-23.
22. Jo rdan A, Chen D, Yi QL, et al. Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data. Vox Sang 2016; 111: 8-15.
23. Tz ounakas VL, Kriebardis AG, Papassideri IS, Antonelou MH. Donor-variation effect on red blood cell storage lesion: A close relationship emerges. Proteomics Clin Appl 2016; 10: 791-804.
24. va n 't Erve TJ, Doskey CM, Wagner BA, et al. Heritability of glutathione and related metabolites in stored red blood cells. Free Radic Biol Med 2014; 76: 107-13.
25. Ha nsen AL, Kurach JD, Turner TR, et al. The effect of processing method on the in vitro characteristics of red blood cell products. Vox Sang 2015; 108: 350-8.
26. Mu lquiney PJ, Bubb WA, Kuchel PW. Model of 2, 3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: In vivo kinetic characterization of 2, 3-bisphosphoglycerate synthase/phosphatase using 13C and 31P NMR. Biochem J 1999; 342: 567-80.
27. Pa glia G, D'Alessandro A, Rolfsson O, et al. Biomarkers defining the metabolic age of red blood cells during cold storage. Blood 2016; 128: E43-50.
28. Bo rdbar A, Johansson PI, Paglia G, et al. Identified metabolic signature for assessing red blood cell unit quality is associated with endothelial damage markers and clinical outcomes. Transfusion 2016; 56: 852-62.
29. D' Alessandro A, Hansen KC, Silliman CC, et al. Metabolomics of AS-5 RBC supernatants following routine storage. Vox Sang 2015; 108: 131-40.
30. D' Alessandro A, Nemkov T, Kelher M, et al. Routine storage of red blood cell (RBC) units in additive solution-3: A comprehensive investigation of the RBC metabolome. Transfusion 2015; 55: 1155-68.
31. D' Alessandro A, Nemkov T, Hansen KC, et al. Red blood cell storage in additive solution-7 preserves energy and redox metabolism: A metabolomics approach. Transfusion 2015; 55: 2955-66.
32. He ss JR, Rugg N, Knapp AD, et al. The role of electrolytes and pH in RBC ASs. Transfusion 2001; 41: 1045-51.
33. He ss JR. Measures of stored red blood cell quality. Vox Sang 2014; 107: 1-9.
34. Lu ten M, Roerdinkholder-Stoelwinder B, Schaap NP, et al. Survival of red blood cells after transfusion: A comparison between red cells concentrates of different storage periods. Transfusion 2008; 48: 1478-85.
35. Na kao K, Wada T, Kamiyama T, et al. A direct relationship between adenosine triphosphate-level and in vivo viability of erythrocytes. Nature 1962; 194: 877-8.
36. Zo lla L, D'Alessandro A. Preface to the Special Issue: Integrated omics. J Proteomics 2012; 76: 3-9.
37. Wh illier S, Raftos JE, Sparrow RL, Kuchel PW. The effects of long-term storage of human red blood cells on the glutathione synthesis rate and steady-state concentration. Transfusion 2011; 51: 1450-9.
38. Me ssana I, Ferroni L, Misiti F, et al. Blood bank conditions and RBCs: The progressive loss of metabolic modulation. Transfusion 2000; 40: 353-60.
39. Le wis IA, Campanella ME, Markley JL, Low PS. Role of band 3 in regulating metabolic flux of red blood cells. Proc Natl Acad Sci USA 2009; 106: 18515-20.
40. Ri nalducci S, D'Amici GM, Blasi B, et al. Peroxiredoxin-2 as a candidate biomarker to test oxidative stress levels of stored red blood cells under blood bank conditions. Transfusion 2011; 51: 1439-49.
41. Ri nalducci S, D'Amici GM, Blasi B, Zolla L. Oxidative stressdependent oligomeric status of erythrocyte peroxiredoxin II (PrxII) during storage under standard blood banking conditions. Biochimie 2011; 93: 845-853.
42. D' Alessandro A, Dzieciatkowska M, Hill RC, Hansen KC. Supernatant protein biomarkers of red blood cell storage hemolysis as determined through an absolute quantification proteomics technology. Transfusion 2016; 56: 1329-39.
43. Ma tte A, Bertoldi M, Mohandas N, et al. Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3. Free Radic Biol Med 2013; 55: 27-35.
44. Bl ackman SM, Piston DW, Beth AH. Oligomeric state of human erythrocyte band 3 measured by fluorescence resonance energy homotransfer. Biophys J 1998; 75: 1117-30.
45. Ri nalducci S, Ferru E, Blasi B, et al. Oxidative stress and caspase-mediated fragmentation of cytoplasmic domain of erythrocyte band 3 during blood storage. Blood Transfus 2012; 10: S55-62.
46. D' Alessandro A, Kriebardis AG, Rinalducci S, et al. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion 2015; 55: 205-19.
47. Zi mring JC, Spitalnik SL, Odem-Davis K. Lost in translation: Signal and frequency amplification in animal modeling. Transfusion 2016; 56: 773-4.
48. Zi mring JC, Spitalnik SL. On the appropriate use and interpretation of animal models in transfusion medicine research. Transfusion 2013; 53: 2334-9.
49. Du mont LJ, D'Alessandro A, Szczepiorkowski ZM, Yoshida T. CO2-dependent metabolic modulation in red blood cells stored under anaerobic conditions. Transfusion 2016; 56: 392-403.
50. Yoshida T, Shevkoplyas SS. Anaerobic storage of red blood cells. Blood Transfus 2010; 8: 220-36.
51. D'Alessandro A, Gevi F, Zolla L. Red blood cell metabolism under prolonged anaerobic storage. Mol Biosyst 2013; 9: 1196-209.
52. D'Alessandro A, Nemkov T, Sun K, et al. AltitudeOmics: Red blood cell metabolic adaptation to high altitude hypoxia. J Proteome Res 2016; 15: 3883-95.
53. Liu H, Zhang Y, Wu H, et al. Beneficial role of erythrocyte adenosine A2B receptor-mediated AMP-activated protein kinase activation in high-altitude hypoxia. Circulation 2016; 134: 405-21.
54. Sun K, Zhang Y, D'Alessandro A, et al. Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia. Nat Commun 2016; 7: 12086.
55. Verkhratsky A, Burnstock G. Biology of purinergic signalling: Its ancient evolutionary roots, its omnipresence and its multiple functional significance. Bioessays 2014; 36: 697-705.
56. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-92.
57. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2014; 240: 31-304.
58. Abbracchio MP, Burnstock G, Boeynaems JM, et al. International Union of Pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006; 58: 281-341.
59. Hoffman JF, Dodson A, Wickrema A, Dib-Hajj SD. Tetrodotoxinsensitive Na+ channels and muscarinic and purinergic receptors identified in human erythroid progenitor cells and red blood cell ghosts. Proc Natl Acad Sci USA 2004; 101: 12370-4.
60. Kimura H, Hamasaki N, Yamamoto M, Tomonaga M. Circulation of red blood cells having high levels of 2, 3-bisphosphoglycerate protects rat brain from ischemic metabolic changes during hemodilution. Stroke 1995; 26: 1431-6; discussion 1436-7.
61. Leal Denis MF, Incicco JJ, Espelt MV, et al. Kinetics of extracellular ATP in mastoparan 7-activated human erythrocytes. Biochim Biophys Acta 2013; 1830: 4692-707.
62. Deyrup IJ. Release of adenine derivatives from mammalian erythrocytes following admixture of blood with strongly hypertonic solutions. Am J Physiol 1951; 167: 749-55.
63. Bergfeld GR, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 1992; 26: 40-7.
64. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH. The erythrocyte as a regulator of vascular tone. Am J Physiol 1995; 269: H2155-61.
65. Wan J, Forsyth AM, Stone HA. Red blood cell dynamics: From cell deformation to ATP release. Integr Biol (Camb) 2011; 3: 972-81.
66. Olearczyk JJ, Stephenson AH, Lonigro AJ, Sprague RS. Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol Heart Circ Physiol 2004; 286: H940-5.
67. Sprague R, Bowles E, Stumpf M, et al. Rabbit erythrocytes possess adenylyl cyclase type II that is activated by the heterotrimeric G proteins Gs and Gi. Pharmacol Rep 2005; 57: 222-8.
68. Sridharan M, Sprague RS, Adderley SP, et al. Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension-induced ATP release. Exp Biol Med (Maywood) 2010; 235: 1142-8.
69. Rogers SC, Said A, Corcuera D, et al. Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance. FASEB J 2009; 23: 3159-70.
70. Adderley SP, Sprague RS, Stephenson AH, Hanson MS. Regulation of cAMP by phosphodiesterases in erythrocytes. Pharmacol Rep 2010; 62: 475-82.
71. Sridharan M, Bowles EA, Richards JP, et al. Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltage-dependent anion channel. Am J Physiol Heart Circ Physiol 2012; 302: H553-9.
72. Olearczyk JJ, Stephenson AH, Lonigro AJ, Sprague RS. NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi. Am J Physiol Heart Circ Physiol 2004; 287: H748-54.
73. Clapp KM, Ellsworth ML, Sprague RS, Stephenson AH. Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O(2) tension-induced ATP release. Am J Physiol Heart Circ Physiol 2013; 304: H660-6.
74. Hanson MS, Stephenson AH, Bowles EA, Sprague RS. Insulin inhibits human erythrocyte cAMP accumulation and ATP release: Role of phosphodiesterase 3 and phosphoinositide 3-kinase. Exp Biol Med (Maywood) 2010; 235: 256-62.
75. Sprague RS, Bowles EA, Achilleus D, Ellsworth ML. Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle. Acta Physiol (Oxf) 2011; 202: 285-92.
76. Rozier MD, Zata VJ, Ellsworth ML. Lactate interferes with ATP release from red blood cells. Am J Physiol Heart Circ Physiol 2007; 292: H3038-42.
77. Kalsi KK, Gonzalez-Alonso J. Temperature-dependent release of ATP from human erythrocytes: Mechanism for the control of local tissue perfusion. Exp Physiol 2012; 97: 419-32.
78. Thuet KM, Bowles EA, Ellsworth ML, et al. The Rho kinase inhibitor Y-27632 increases erythrocyte deformability and low oxygen tension-induced ATP release. Am J Physiol Heart Circ Physiol 2011; 301: H1891-6.
79. Raththagala M, Karunarathne W, Kryziniak M, et al. Hydroxyurea stimulates the release of ATP from rabbit erythrocytes through an increase in calcium and nitric oxide production. Eur J Pharmacol 2010; 645: 32-8.
80. Gonzalez-Alonso J. ATP as a mediator of erythrocytedependent regulation of skeletal muscle blood flow and oxygen delivery in humans. J Physiol 2012; 590: 5001-13.
81. Collins DM, McCullough WT, Ellsworth ML. Conducted vascular responses: Communication across the capillary bed. Microvasc Res 1998; 56: 43-53.
82. Dietrich HH, Ellsworth ML, Sprague RS, Dacey RG Jr. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol 2000; 278: H1294-8.
83. Kirby BS, Voyles WF, Carlson RE, Dinenno FA. Graded sympatholytic effect of exogenous ATP on postjunctional alpha-adrenergic vasoconstriction in the human forearm: Implications for vascular control in contracting muscle. J Physiol 2008; 586: 4305-16.
84. Sprague RS, Stephenson AH, Bowles EA, et al. Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes 2006; 55: 3588-93.
85. Sprague RS, Stephenson AH, Ellsworth ML, et al. Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med (Maywood) 2001; 226: 434-9.
86. Zhu H, Zennadi R, Xu BX, et al. Impaired adenosine-5'-triphosphate release from red blood cells promotes their adhesion to endothelial cells: A mechanism of hypoxemia after transfusion. Crit Care Med 2011; 39: 2478-86.
87. Cekic C, Linden J. Purinergic regulation of the immune system. Nat Rev Immunol 2016; 16: 177-92.
88. Eltzschig HK, Ibla JC, Furuta GT, et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003; 198: 783-96.
89. Kong T, Westerman KA, Faigle M, et al. HIF-dependent induction of adenosine A2B receptor in hypoxia. Faseb J 2006; 20: 2242-50.
90. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011; 364: 656-65.
91. Eltzschig HK, Thompson LF, Karhausen J, et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: Coordination by extracellular nucleotide metabolism. Blood 2004; 104: 3986-92.
92. Colgan SP, Taylor CT. Hypoxia: An alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 2011; 7: 281-7.
93. D'Alessandro A, Liumbruno G, Grazzini G, Zolla L. Red blood cell storage: The story so far. Blood Transfus 2010; 8: 82-8.
94. Zhang Y, Dai Y, Wen J, et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat Med 2011; 17: 79-86.
95. Wang S, Dale GL, Song P, et al. AMPKalpha1 deletion shortens erythrocyte life span in mice: Role of oxidative stress. J Biol Chem 2010; 285: 19976-85.
96. Foller M, Sopjani M, Koka S, et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009; 23: 1072-80.
97. Zimring JC. Widening our gaze of red blood storage haze: A role for metabolomics. Transfusion 2015; 55: 1139-42.
98. Zubair AC. Clinical impact of blood storage lesions. Am J Hematol 2010; 85: 117-22.
99. Eckle T, Krahn T, Grenz A, et al. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007; 115: 1581-90.
100. Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: A clinical review. Lancet 2013; 382: 984-94.
101. Eckle T, Koeppen M, Eltzschig HK. Role of extracellular adenosine in acute lung injury. Physiology (Bethesda) 2009; 24: 298-306.